Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukemic cells

Bioelectromagnetics

Volumn 22, Issue 7, 2001, Pages 470-478

  Holandino, Carla ^b   Veiga, Venício F ^b   Rodrigues, Marcio L ^b   Morales, Marcelo M ^b   Capella, Marcia A M ^a   Alviano, Celuta S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Inst Microbiol Prof Paulo de Goes ^*

Author keywords

DC; Electric stimulation; Human leukemic cells; Multidrug resistance; Tumor growth inhibition

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; ELECTROPHORESIS; ELECTROPHYSIOLOGY; GENE ENCODING; GLYCOPROTEINS; POLYMERASE CHAIN REACTION; TRANSCRIPTION; TUMORS;

CELLULAR EFFECTS; CURRENT TREATMENTS; DIRECT-CURRENT; ELECTRIC STIMULATION; GROWTH INHIBITION; HUMAN LEUKEMIC CELLS; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; TUMOR GROWTH; TUMOR GROWTH INHIBITION;

HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY;

GLYCOPROTEIN P; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL STRAIN K 562; CELL SURVIVAL; CYTOLOGY; ELECTROSTIMULATION; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MULTIDRUG RESISTANCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DIVISION; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; ELECTRIC STIMULATION; FLOW CYTOMETRY; HUMANS; K562 CELLS; MICE; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0035489095     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/bem.75     Document Type: Article

References (47)

1. Altenberg GA, Vanoye CG, Han ES, Deitmer JW, Reuss L. 1994. Relationships between Rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein. J Biol Chem 269(10):7145-7149.
2. Capella LS, Alcantara JS, Moura-Neto V, Lopes AG, Capella MAM. 2000. Vanadate is toxic to adherent-growing multidrug resistant cells. Tumor Biol 21:54-62.
3. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyonate-phenol-chloroform extraction. Anal Biochem 162:156-159.
4. Chou CK, Mc Dougall JA, Ahn C, Vora N. 1997. Electrochemical treatment of mouse and rat fibrosarcomas with direct current. Bioelectromagnetics 18:14-24.
5. Chudomel V, Soucek J, Hruba A, Jerabek J, Schwarz J, Smetana K. 1989. Positive effect of direct current on cytotoxicity of human lymphocytes. Neoplasma 36(5):573-582.
6. Clen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB. 1990. Genomic organization of the human multidrug resistance (MDR-1) gene and origin of P-glycoproteins. J Biol 265:506-514.
7. David SL, Absolom DR, Smith CR, Gams J, Herbert MA. 1985. Effect of low level direct current on in vivo tumor growth in hamsters. Cancer Res 45:5625-5631.
8. Denis-Gay M, Petit JM, Ratinaud MH. 1995. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells? Anticancer Res 15(1): 121-126.
9. Forman HJ, Fridovich I. 1972. Electrolytic univalent reduction of oxygen in aqueous solution demonstrated with superoxide dismutase. Science 175:339.
10. Freshney RI. 1994. Culture of animal cells: a manual of basic technique. In New York: Wiley-Liss. 80-83.
11. Ghadially FN. 1982. Ultrastructural pathology of the cell and matrix. In London: 2nd Ed. 1-12.
12. Gottesman MM, Pastan I. 1988. The multidrug transporter, a double-edged sword. J Biol Chem 265:12163-12166.
13. Graslund A, Ehrenberg A, Thelander L. 1982. Characterization of the free-radical of mammalian ribonucleotide reductase. J Biol Chem 257:5711-5715.
14. Griffin DT, Dodd NJ, Moore JV, Pullan BR, Taylor TV. 1994. The effects of low-level direct-current therapy on a preclinical mammary carcinoma: tumor regression and systemic biochemical sequel. Br J Cancer 69:875-878.
15. Heiberg E, Nalesnik WJ, Janney C. 1991. Effects of varying potential and electrolytic dosage in direct current treatment of tumors. Acta Radiol 32(2):174-177.
16. Holandino CQ, Veiga VF, Capella MAM, Menezes S and Alviano CS. 2000. Damage induction by direct electric current in tumoral target cells (P815). Indian J Exp Biol 38:554-558.
17. Humphrey CE, Seal EH. 1959. Biophysical approach toward tumor regression in mice. Science 130:388-389.
18. Jaroszeski MJ, Gilbert RA, Heller R. 1997. In vivo antitumor effects of electrochemotherapy in a hepatoma model. Biochim Biophys Acta 1334:15-18.
19. Juliano RL, Ling V. 1978. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162.
20. Kulsh J. 1997. Targeting a key enzyme in cell growth: a novel therapy for cancer. Med Hypotheses 49:297-300.
21. Kuo ML, Kinsella TJ. 1998. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells. Cancer Res 58(10):2245-2252.
22. Kurokawa M, Sakagami H, Kokubu F, Noda H, Takeda M, Adachi M. 1997. Induction of apoptotic cell death by direct-current treatment in human leukemic cell lines. J Cancer Res Clin Oncol 123:370-376.
23. Lewis PR, Knight DP. 1991. Staining methods for sectioned material. In: Audrey M. Glauert, editor. Amsterdam, New York, Oxford: North-Holland Publishing Company, pp 2-47.
24. Li K, Xin Y, Gu Y, Xu B, Fan D, Ni B. 1997. Effects of direct current on dog liver: possible mechanisms for tumor electrochemical treatment. Bioelectromagnetics 18(1):2-7.
25. Marino AA, Morris D, Arnold T. 1986. Electrical treatment of Lewis lung carcinoma in mice. J Surg Res 41:198-201.
26. Mau BL, Powis G. 1992. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity. Biochem Pharmacol 43(7): 1621-1627.
27. Mir LM, Glass LF, Sersa G, Teissié J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reinigen DS, Rudolf Z, Belehradek M, Gilbert R, Rols M-P, Belehradek J Jr, Bachaud JM, DeConti R, Stabuc B, Cemazar M, Coninx P, Heller R. 1998. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77:2336-2342.
28. Morales MM, Capella MAM, Sanches MV, Lopes AG, Guggino WB. 2000. Modulation of the mdr-1b gene in the kidney of rats subjected to dehydration or a high-salt diet. Eur J Physiol 439:356-362.
29. Myette MS, Elford HL, Chitambar CR. 1998. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells. Cancer Lett 129(2):199-204.
30. Neyfalkh AA. 1988. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174:168-176.
31. Nooter K, Herweijer H. 1991. Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63:663-669.
32. Nordeström BWE. 1994. Electrostatic field interference with cellular and tissue function, leading to dissolution of metastases that enhances the effect of chemotherapy. Eur J Surg Suppl 574:93-109.
33. Patterson MK Jr. 1979. Measurement of growth and viability of cells in culture. In: Jakoby WB, Pastan IH, editors. Methods in enzymology, Vol. 58. New York: Academic Press, pp 141-152.
34. Ponte P, Ng SY, Engel J, Gunning P, Kedes E. 1984. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12(3):1687-1696.
35. Ramirez EH, Orlowski S, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck J-N, Mir LM. 1998. Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77:2104-2111.
36. Schauble MK, Habal MB, Gullick HD. 1977. Inhibition of experimental tumour growth in hamsters by small direct currents. Arch Pathol Lab Med 101:249-297.
37. Szekeres T, Fritzer-Szekeres M, Elford HE. 1997. The ezyme ribonucleotide reductase: target for antitumor and anti-HIV therapy. Crit Ver Clin Lab Sci 34(6):503-528.
38. Szekeres T, Gharehbaghi K, Fritzer M, Woody M, Srivastava A, van't Riet B, Jayaram HN, Elford HL. 1994. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase. Cancer Chemother Pharmacol 34(1):63-66.
39. Trindade GS, Capella MAM, Capella ES, Affonso-Mitidieri OR, Rumjanek VM. 1999. Differences in sensitivity to UVC, UVB, and UVA radiation of a multidrug-resistant cell line overexpressing P-glycoprotein. Photochem Photobiol 69(6):694-699.
40. Trindade GS, Farias SLA, Rumjanek VM, Capella MAM. 2000. Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett 151:161-167.
41. Turler A, Schaefer H, Schaefer N, Wagner M, Maintz D, Qiao JC, Hoelscher AH. 2000. Experimental low-level direct current therapy in liver metastases: influence of polarity and current dose. Bioelectromagnetics 21(5): 395-401.
42. Veiga VF, Holandino C, Rodrigues ME, Capella MAM, Menezes S, Alviano CS. 2000. Cellular damage and altered carbohydrate expression in P815 tumor cells induced by direct electric current: an in vitro analysis. Bioelectromagnetics 21(8):597-607.
43. Walter RJ, Shtil AA, Roninson IB, Holian O. 1997. 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation. Radiat Res 147:369-375.
44. Xin Y, Xue F, Ge B, Zhao F, Shi B, Zhang W. 1997a. Electrochemical treatment of lung cancer. Bioelectromagnetics 18(1):8-13.
45. Xin Y, Xue F, Zhao F. 1997b. Effectiveness of electrochemical therapy in the treatment of lung cancers of middle and late stage. Chin Med J 110(5):379-383.
46. Xin YL. 1993. Traditional and Western medical treatment of 211 cases of late stage lung cancer. Chung Ku Chung Hsi I Chieh Ho Tsa Chih 13(3):135-213.
47. Yen Y, Li JR, Zou BS, Rojas F, Yu J, Chou CK. 1999. Electrochemical treatment of human KB cells in vitro. Bioelectromagnetics 20(1):34-41.